ResMed | RMD - 市值

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 33.59B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	市值	更改		日
Ansell	USD 3.36B		450.92M	2025-12
Artivion	USD 2.18B		176M	2025-12
AtriCure	USD 1.42B		28M	2026-06
Baxter International	USD 11.01B		2.34B	2026-06
Cochlear	AUD 17.05B		2.6B	2025-12
Cooper Companies	USD 12.27B		3.68B	2026-03
CSL	USD 55.89B		20.42B	2025-12
Dexcom	USD 25.99B		1.82B	2026-06
Edwards Lifesciences	USD 52.09B		5.92B	2026-06
Fisher Paykel Healthcare	NZD 21.96B		201.12M	2026-06
Globus Medical	USD 10.73B		963M	2026-06
Haemonetics	USD 3.51B		963M	2026-06
Idexx Laboratories	USD 41.53B		3.1B	2026-06
Insulet	USD 10.55B		3.99B	2026-06
Integra LifeSciences	USD 1.4B		664M	2026-06
Intuitive Surgical	USD 140.84B		22.89B	2026-06
Medtronic	USD 113.81B		4.51B	2026-09
Philips	EUR 23.09B		615.44M	2026-06
Ramsay Health Care	AUD 7.93B		537.83M	2025-12
ResMed	USD 28.27B		4.43B	2026-06
Sigma Healthcare	AUD 2.68B		2.01B	2026-09
Steris	USD 20.52B		1.16B	2026-06
Teleflex	USD 5.61B		317M	2026-06
Thermo Fisher Scientific	USD 190.65B		7.99B	2026-06